NIOX Group PLC is a medical device company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has a single operating segment: NIOX. The NIOX ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

NIOX Group, which designs and sells medical devices for asthma diagnosis and management, has announced a series of board changes, including a new CEO and finance chief. Jonathan Emms, currently the ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

Operating profit is forecast to rise to GBP8.4 million from GBP8.0 million. Niox Group PLC - Oxford-based developer of medical devices for asthma diagnosis and management - Expects revenue of ...

Oxford, UK - 16 January 2025: NIOX Group plc ("NIOX", the "Company" or the "Group"; AIM: NIOX), a medical device company focused on point of care asthma diagnosis, monitoring and management ...

With its stock down 5.6% over the past three months, it is easy to disregard NIOX Group (LON:NIOX). However, stock prices are usually driven by a company’s financial performance over the long term, ...

With its stock down 5.6% over the past three months, it is easy to disregard NIOX Group (LON:NIOX). However, stock prices are usually driven by a company’s financial performance over the long ...